Year |
Citation |
Score |
2023 |
Al-Awadhi FH, Simon EF, Liu N, Ratnayake R, Paul VJ, Luesch H. Discovery and Anti-Inflammatory Activity of a Cyanobacterial Fatty Acid Targeting the Keap1/Nrf2 Pathway. Marine Drugs. 21. PMID 37999377 DOI: 10.3390/md21110553 |
0.7 |
|
2020 |
Al-Hasawi NA, Phillips OA, Al-Awadhi F, Sharaf LH, Amine SA, Novotny L. Anti-progressive Effects of a Series of Glycinyl and Alaninyl Triazolyl-oxazolidinones on Kelly Neuroblastoma Cell Line. Anticancer Research. 40: 5125-5140. PMID 32878801 DOI: 10.21873/Anticanres.14516 |
0.431 |
|
2020 |
Al-Awadhi FH, Salvador-Reyes LA, Elsadek LA, Ratnayake R, Chen QY, Luesch H. Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases. Acs Chemical Neuroscience. PMID 32559056 DOI: 10.1021/Acschemneuro.0C00093 |
0.694 |
|
2020 |
Al-Awadhi FH, Luesch H. Targeting eukaryotic proteases for natural products-based drug development. Natural Product Reports. 37: 827-860. PMID 32519686 DOI: 10.1039/C9Np00060G |
0.63 |
|
2020 |
Al-Awadi NA, Mohamed AS, Habib OM, Al-Awadhi FH, Al-Jalal NA, Ibrahim YA. Flash vacuum pyrolysis of acetylenic esters: A mechanistic study Journal of Analytical and Applied Pyrolysis. 146: 104778. DOI: 10.1016/J.Jaap.2020.104778 |
0.391 |
|
2018 |
Al-Awadhi FH, Gao B, Rezaei MA, Kwan JC, Li C, Ye T, Paul VJ, Luesch H. Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium. Journal of Medicinal Chemistry. PMID 30015488 DOI: 10.1021/Acs.Jmedchem.8B00885 |
0.753 |
|
2018 |
Al-Awadhi FH, Paul VJ, Luesch H. Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer. Chembiochem : a European Journal of Chemical Biology. PMID 29405541 DOI: 10.1002/Cbic.201700627 |
0.653 |
|
2018 |
Al-Awadhi FH, Paul VJ, Luesch H. Cover Feature: Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer (ChemBioChem 8/2018) Chembiochem. 19: 765-765. DOI: 10.1002/Cbic.201800138 |
0.601 |
|
2017 |
Al-Awadhi FH, Law BK, Paul VJ, Luesch H. Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer. Journal of Natural Products. PMID 29087712 DOI: 10.1021/Acs.Jnatprod.7B00551 |
0.66 |
|
2017 |
Al-Awadhi FH, Salvador LA, Law BK, Paul VJ, Luesch H. Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer. Marine Drugs. 15. PMID 28926939 DOI: 10.3390/Md15090290 |
0.708 |
|
2016 |
Al-Awadhi FH, Ratnayake R, Paul VJ, Luesch H. Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium. Bioorganic & Medicinal Chemistry. PMID 27211244 DOI: 10.1016/J.Bmc.2016.04.062 |
0.727 |
|
2015 |
Al-Awadhi F, Paul V, Luesch H. Isolation, structure elucidation and biological evaluation of novel cathepsin inhibitors from marine cyanobacteria Planta Medica. 81. DOI: 10.1055/S-0035-1556352 |
0.567 |
|
2014 |
Salvador LA, Park H, Al-Awadhi FH, Liu Y, Kim B, Zeller SL, Chen QY, Hong J, Luesch H. Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties. Acs Medicinal Chemistry Letters. 5: 905-10. PMID 25147612 DOI: 10.1021/Ml500170R |
0.648 |
|
Show low-probability matches. |